RecruitingPhase 1Phase 2NCT04684602
Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
Evaluation of the Safety, Tolerability and Efficacy of Regenerative Therapy for the Treatment of Various Chronic and Acute Conditions
Sponsor
Thomas Advanced Medical LLC
Enrollment
5,000 participants
Start Date
Jul 9, 2020
Study Type
INTERVENTIONAL
Conditions
Summary
This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial findings and an extensive body of research indicate regenerative treatments are both safe and effective for the treatment of multiple conditions.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Age 18 and older
- Ability to provide informed consent
- Availability for follow up visits
Exclusion Criteria3
- Active or recent malignancy (within last 2 years)
- Pregnancy or breast-feeding
- Inability to provide informed consent
Interventions
BIOLOGICALPrimePro™/ PrimeMSK™
Injection via condition specific route of administration.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04684602
Related Trials
Evaluation and Treatment of Neurosurgical Disorders
NCT000605411 location
Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases
NCT065486071 location
Study to Evaluate the Safety and Feasibility of Diamyd® in Individuals at Risk for Type 1 Diabetes
NCT056839901 location
Ovarian Tissue Cryopreservation for Fertility Preservation
NCT058751551 location
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
NCT065754261 location